Concepedia

Fiona Kwok

FK

Statistics

Publications

9

Citations

1.2K

H-Index

9

Active since

2016

Affiliations

Westmead Hospital(Current)

Heidelberg University

National and Kapodistrian University of Athens

University College London

University of Pavia

Fiona Kwok is an author at Westmead Hospital specializing in pharmacotherapy, amyloid formation, and clinical pharmacology.

Publications per year

2016–2024

9

Publications

9

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

, , +15

Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf et al. · Journal of Clinical Oncology · 2020 · 146 citations · Full text

, , +14

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf et al. · Blood · 2016 · 62 citations

, , +8

A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis

Angela Dispenzieri, Efstathios Kastritis, Ashutosh Wechalekar et al. · Leukemia · 2021 · 59 citations · Full text

, , +12

1–5 of 9